Logo image of LYL

DRAGON VICTORY INTERNATIONAL (LYL) Stock Fundamental Analysis

NASDAQ:LYL - Nasdaq - KYG283651076 - Common Stock - Currency: USD

0.5004  -0.05 (-9.02%)

After market: 0.5002 0 (-0.04%)

Fundamental Rating

2

Taking everything into account, LYL scores 2 out of 10 in our fundamental rating. LYL was compared to 53 industry peers in the Consumer Finance industry. LYL has a great financial health rating, but its profitability evaluates not so good. LYL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LYL has reported negative net income.
In the past year LYL has reported a negative cash flow from operations.
LYL had negative earnings in 4 of the past 5 years.
LYL had negative operating cash flow in 4 of the past 5 years.
LYL Yearly Net Income VS EBIT VS OCF VS FCFLYL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -5M -10M

1.2 Ratios

The profitability ratios for LYL are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LYL Yearly ROA, ROE, ROICLYL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LYL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LYL Yearly Profit, Operating, Gross MarginsLYL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -5K -10K -15K -20K

7

2. Health

2.1 Basic Checks

LYL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LYL has been increased compared to 1 year ago.
There is no outstanding debt for LYL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LYL Yearly Shares OutstandingLYL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
LYL Yearly Total Debt VS Total AssetsLYL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -0.30, we must say that LYL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LYL (-0.30) is better than 83.64% of its industry peers.
LYL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACC7.3%
LYL Yearly LT Debt VS Equity VS FCFLYL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M

2.3 Liquidity

LYL has a Current Ratio of 2.36. This indicates that LYL is financially healthy and has no problem in meeting its short term obligations.
LYL has a Current ratio of 2.36. This is amongst the best in the industry. LYL outperforms 87.27% of its industry peers.
LYL has a Quick Ratio of 2.36. This indicates that LYL is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LYL (2.36) is better than 87.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.36
Quick Ratio 2.36
LYL Yearly Current Assets VS Current LiabilitesLYL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

1

3. Growth

3.1 Past

LYL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.81%.
Looking at the last year, LYL shows a very strong growth in Revenue. The Revenue has grown by 848.36%.
LYL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.70% yearly.
EPS 1Y (TTM)-63.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.94%
Revenue 1Y (TTM)848.36%
Revenue growth 3Y-7.91%
Revenue growth 5Y-9.7%
Sales Q2Q%421.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LYL Yearly Revenue VS EstimatesLYL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M
LYL Yearly EPS VS EstimatesLYL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022

0

4. Valuation

4.1 Price/Earnings Ratio

LYL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LYL Price Earnings VS Forward Price EarningsLYL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LYL Per share dataLYL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LYL!.
Industry RankSector Rank
Dividend Yield N/A

DRAGON VICTORY INTERNATIONAL

NASDAQ:LYL (12/12/2022, 8:00:27 PM)

After market: 0.5002 0 (-0.04%)

0.5004

-0.05 (-9.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.39%
Inst Owner Change-92.87%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.81M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.48
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)-0.72
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.09
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 443.72%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.36
Quick Ratio 2.36
Altman-Z -0.3
F-Score4
WACC7.3%
ROIC/WACCN/A
Cap/Depr(3y)148.01%
Cap/Depr(5y)1544.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)848.36%
Revenue growth 3Y-7.91%
Revenue growth 5Y-9.7%
Sales Q2Q%421.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.16%
OCF growth 3YN/A
OCF growth 5YN/A